Candel Therapeutics (CADL) Total Debt (2020 - 2025)

Candel Therapeutics' Total Debt history runs 6 years deep, the most recent figure standing at $1.0 million for Q4 2025.

• In Q4 2025, Total Debt fell 90.64% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (down 90.64% YoY), while the FY2025 annual figure was $1.0 million, down 90.64% from the prior year.
• Total Debt came in at $1.0 million for Q4 2025 at Candel Therapeutics, down from $4.2 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $20.5 million in Q4 2023 to a low of $560000.0 in Q4 2021.
• A 5-year average of $11.6 million and a median of $10.7 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt jumped 3507.5% in 2022 and plunged 90.64% in 2025, its largest moves.
• Candel Therapeutics' Total Debt stood at $560000.0 in 2021, then surged by 3507.5% to $20.2 million in 2022, then gained by 1.6% to $20.5 million in 2023, then sank by 47.55% to $10.8 million in 2024, then slumped by 90.64% to $1.0 million in 2025.
• According to Business Quant data, Total Debt over the past three periods registered $1.0 million, $4.2 million, and $6.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison